Follow the JW신약 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, JW신약 has logged 24 insider filings. Market capitalisation: €94.5bn. The latest transaction was filed on 5 March 2026 (Other). Among the most active insiders: JW홀딩스. The full history is free.
24
Insider Decl.
n/a
Thresholds
n/a
19 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 1,007 of 28,836 companies
81.1
score / 100
Value
82
Quality
80
FCF yld4.7%
Earn yld17%
EV/EBITDA5.9x
ROE·
Gross mgn50%
Net mgn19%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
JW신약 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative drugs and therapeutic solutions.